Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 11:11:1416006.
doi: 10.3389/fmed.2024.1416006. eCollection 2024.

Structural and genomic evolutionary dynamics of Omicron variant of SARS-CoV-2 circulating in Madhya Pradesh, India

Affiliations

Structural and genomic evolutionary dynamics of Omicron variant of SARS-CoV-2 circulating in Madhya Pradesh, India

Suman Dhankher et al. Front Med (Lausanne). .

Abstract

The SARS-CoV-2 Omicron (B.1.1.529) variant emerged in early November 2021 and its rapid spread created fear worldwide. This was attributed to its increased infectivity and escaping immune mechanisms. The spike protein of Omicron has more mutations (>30) than any other previous variants and was declared as the variant of concern (VOC) by the WHO. The concern among the scientific community was huge about this variant, and a piece of updated information on circulating viral strains is important in order to better understand the epidemiology, virus pathogenicity, transmission, therapeutic interventions, and vaccine development. A total of 710 samples were processed for sequencing and identification up to a resolution of sub-lineage. The sequence analysis revealed Omicron variant with distribution as follows: B.1.1, B.1.1.529, BA.1, BA.2, BA.2.10, BA.2.10.1, BA.2.23, BA.2.37, BA.2.38, BA.2.43, BA.2.74, BA.2.75, BA.2.76, and BA.4 sub-lineages. There is a shift noted in circulating lineage from BA.1 to BA.2 to BA.4 over a period from January to September 2022. Multiple signature mutations were identified in S protein T376A, D405N, and R408S mutations, which were new and common to all BA.2 variants. Additionally, R346T was seen in emerging BA.2.74 and BA.2.76 variants. The emerging BA.4 retained the common T376A, D405N, and R408S mutations of BA.2 along with a new mutation F486V. The samples sequenced were from different districts of Madhya Pradesh and showed a predominance of BA.2 and its variants circulating in this region. The current study identified circulation of BA.1 and BA.1.1 variants during initial phase. The predominant Delta strain of the second wave has been replaced by the Omicron variant in this region over a period of time. This study successfully deciphers the dynamics of the emergence and replacement of various sub-lineages of SARS-CoV-2 in central India on real real-time basis.

Keywords: BA.2; COVID-19; Epidemiology; Genome; Lineage; NGS.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
District-wise distribution of sequenced Omicron sub-lineages of SARS-CoV-2.
Figure 2
Figure 2
qRT-PCR using SARS-CoV-2 specific primers and probes for the O/N/S gene.
Figure 3
Figure 3
Distribution of Omicron variants in districts of Madhya Pradesh.
Figure 4
Figure 4
Phylogenetic tree showing the distribution of Omicron variants sequenced in this study.
Figure 5
Figure 5
Phylogenetic tree showing the distribution of sequenced Omicron variants in different clades from districts of Madhya Pradesh.
Figure 6
Figure 6
The maximum number of events in AA changes seen in the spike region of Omicron variants sequenced from the regions of Madhya Pradesh.
Figure 7
Figure 7
ACE-2-RBD of Omicron variants interaction and important mutations in the RBD region of the different variants of Omicron sequenced from this region.

Similar articles

References

    1. World Health Organization (WHO) . WHO coronavirus (COVID-19) dashboard. Available at: https://covid19.who.int/ (Accessed February 20, 2024).
    1. Ren SY, Wang WB, Gao RD, Zhou AM. Omicron variant (B.1.1.529) of SARS-CoV-2: mutation, infectivity, transmission, and vaccine resistance. World J Clin Cases. (2022) 10:1–11. doi: 10.12998/wjcc.v10.i1.1, PMID: - DOI - PMC - PubMed
    1. He X, Hong W, Pan X, Lu G, Wei X. SARS-CoV-2 Omicron variant: characteristics and prevention. MedComm. (2021) 2:838–45. doi: 10.1002/mco2.110 - DOI - PMC - PubMed
    1. Hoffmann M, Krüger N, Schulz S, Cossmann A, Rocha C, Kempf A, et al. . The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic. Cell. (2022) 185:447–456.e11. doi: 10.1016/j.cell.2021.12.032, PMID: - DOI - PMC - PubMed
    1. Thakur V, Ratho RK. OMICRON (B.1.1.529): a new SARS‐CoV‐2 variant of concern mounting worldwide fear. J Med Virol. (2022) 94:1821–4. doi: 10.1002/jmv.27541 - DOI - PubMed

LinkOut - more resources